ATE491448T1 - Verfahren zur herstellung eines krebsimpfstoffs - Google Patents
Verfahren zur herstellung eines krebsimpfstoffsInfo
- Publication number
- ATE491448T1 ATE491448T1 AT07250445T AT07250445T ATE491448T1 AT E491448 T1 ATE491448 T1 AT E491448T1 AT 07250445 T AT07250445 T AT 07250445T AT 07250445 T AT07250445 T AT 07250445T AT E491448 T1 ATE491448 T1 AT E491448T1
- Authority
- AT
- Austria
- Prior art keywords
- dendritic cells
- producing
- cancer
- tumour cell
- cancer vaccine
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229940022399 cancer vaccine Drugs 0.000 title 1
- 238000009566 cancer vaccine Methods 0.000 title 1
- 210000004443 dendritic cell Anatomy 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 239000013592 cell lysate Substances 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 229930003802 tocotrienol Natural products 0.000 abstract 1
- 239000011731 tocotrienol Substances 0.000 abstract 1
- 235000019148 tocotrienols Nutrition 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/428—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20060439A MY160857A (en) | 2006-02-03 | 2006-02-03 | A cancer vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE491448T1 true ATE491448T1 (de) | 2011-01-15 |
Family
ID=38057880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07250445T ATE491448T1 (de) | 2006-02-03 | 2007-02-02 | Verfahren zur herstellung eines krebsimpfstoffs |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7776324B2 (de) |
| EP (1) | EP1815856B1 (de) |
| JP (1) | JP5303113B2 (de) |
| AT (1) | ATE491448T1 (de) |
| DE (1) | DE602007011123D1 (de) |
| MY (1) | MY160857A (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY148321A (en) * | 2007-10-02 | 2013-03-29 | Malaysian Palm Oil Board Mpob | Vitamin e supplementation to tetanus toxoid |
| SG11201401632WA (en) * | 2011-10-20 | 2014-05-29 | California Stem Cell Inc | Antigen presenting cancer vaccine |
| CN110885788B (zh) * | 2019-12-13 | 2021-08-17 | 北京和合医学诊断技术股份有限公司 | 人肠癌原代细胞、应用和培养方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458585B1 (en) * | 1996-08-14 | 2002-10-01 | Nexell Therapeutics Inc. | Cytokine-free culture of dendritic cells |
| SK822003A3 (en) * | 2000-07-28 | 2004-05-04 | Liponova Gmbh | Medicament for the immunotherapy of malignant tumours |
| US7651686B2 (en) * | 2001-10-09 | 2010-01-26 | Mayo Foundation For Medical Education And Research | Enhancement of immune responses by 4-1bb-binding agents |
| EP1567014B1 (de) * | 2002-12-04 | 2011-09-28 | Baylor Research Institute | Einstufiges schnellverfahren zurherstellung eines antigenbeladenen dendritenzellimpfstoffs aus vorstufen |
| ES2532997T3 (es) * | 2005-04-22 | 2015-04-06 | Elizabeth Stuart | Uso de tocotrienoles de vitamina E para la inhibición del patógeno intracelular obligado Chlamydia |
-
2006
- 2006-02-03 MY MYPI20060439A patent/MY160857A/en unknown
-
2007
- 2007-02-02 EP EP07250445A patent/EP1815856B1/de not_active Not-in-force
- 2007-02-02 DE DE602007011123T patent/DE602007011123D1/de active Active
- 2007-02-02 AT AT07250445T patent/ATE491448T1/de not_active IP Right Cessation
- 2007-02-03 US US11/670,967 patent/US7776324B2/en not_active Expired - Fee Related
- 2007-02-05 JP JP2007025080A patent/JP5303113B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP5303113B2 (ja) | 2013-10-02 |
| DE602007011123D1 (de) | 2011-01-27 |
| US20070231351A1 (en) | 2007-10-04 |
| JP2007254458A (ja) | 2007-10-04 |
| MY160857A (en) | 2017-03-31 |
| EP1815856B1 (de) | 2010-12-15 |
| EP1815856A2 (de) | 2007-08-08 |
| US7776324B2 (en) | 2010-08-17 |
| EP1815856A3 (de) | 2008-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005019064D1 (de) | Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren | |
| NO20092522L (no) | Sammensetninger og fremgangsmater for a behandle kreft med cupredoxiner og CPG rikt DNA | |
| BR112012031727A2 (pt) | conjugado de droga-anticorpo, composição farmacêutica, uso do conjugado de droga-anticorpo, método para induzir a eliminação celular ou inibir o crescimento e/ou a proliferação de uma célula tumoral, e, método de tratamento de doença. | |
| BRPI0814330B8 (pt) | métodos e kits cirúrgicos | |
| BRPI0921726B8 (pt) | método para preparar uma composição de implante para promover o crescimento ósseo em um mamífero | |
| EA200801074A1 (ru) | Способы получения искусственных гибридных семян | |
| WO2008039874A3 (en) | Cancer stem cell antigen vaccines and methods | |
| GB2441939A (en) | Surgical membrane | |
| EA200802213A1 (ru) | Способы лечения заболеваний крови | |
| WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
| IN2014MN01981A (de) | ||
| CL2008002089A1 (es) | Compuesto para la regeneracion de tejidos que comprende al menos una sustancia derivada de sangre y acido hialuronico y/o al menos un compuesto derivado de acido hialuronico; metodo para la prepararcion de dicho compuesto. | |
| NO20090598L (no) | 6,9-disubstituerte purinderivater og deres anvendelse for behandling av hud | |
| MX351889B (es) | Composiciones y métodos anti-cxcr1. | |
| GB2497475A (en) | Kits, components and methods for tissue reconstruction | |
| EA201001749A1 (ru) | Способ лечения недифференцированного артрита | |
| EP2560002A3 (de) | Verfahren zum Isolieren und/oder Identifizieren mesenchymaler Stammzellen | |
| FR2975890B1 (fr) | Systeme et procede de tracabilite d'un systeme d'instrumentation chirurgicale | |
| WO2007137827A8 (de) | Isoliertes naturidentisches kollagen | |
| EA201290107A1 (ru) | Способ определения пациента как восприимчивого или не восприимчивого к иммунотерапии | |
| WO2009147658A3 (en) | Compositions and methods for diagnosis, prognosis and treatment of mesothelioma | |
| ATE552866T1 (de) | Verfahren zur herstellung eines azellulären organischen gewebes | |
| ATE491448T1 (de) | Verfahren zur herstellung eines krebsimpfstoffs | |
| WO2010101358A3 (ko) | 세포 또는 조직 배양용 기구 | |
| AR074406A1 (es) | Celulas madre terapeuticas derivadas de monocitos humanos y un metodo para inducir celulas madre terapeuticas derivadas de monocitos humanos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |